Allogene Therapeutics

About:

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Website: http://allogene.com

Twitter/X: AllogeneTx

Top Investors: TPG, Pfizer, Gilead Sciences, Fidelity, Franklin Templeton

Description:

Allogene Therapeutics is a clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 which is developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies.